Session » Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Safety I
-
Abstract Number: 1640
Long-Term Safety of Tocilizumab in Patients with Rheumatoid Arthritis and a Mean Treatment Duration of 3.7 Years
-
Abstract Number: 1642
Biologics and Mortality Risk in Rheumatoid Arthritis – Results of a Population Based Study
-
Abstract Number: 1643
Outcomes of Pregnancy in Subjects Exposed to Certolizumab Pegol